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The transcription factor Foxp1 preserves integrity of
an active Foxp3 locus in extrathymic Treg cells
Sayantani Ghosh1,2, Sinchita Roy-Chowdhuri3, Keunsoo Kang4, Sin-Hyeog Im 1,2 & Dipayan Rudra1,2
Regulatory T (Treg) cells, which are broadly classiﬁed as thymically derived (tTreg) or
extrathymically induced (iTreg), suppress immune responses and display stringent depen-
dence to the transcription factor Foxp3. However precise understanding of molecular events
that promote and preserve Foxp3 expression in Treg cells is still evolving. Here we show that
Foxp1, a forkhead transcription factor and a sibling family member of Foxp3, is essential for
sustaining optimal expression of Foxp3 speciﬁcally in iTreg cells. Deletion of Foxp1 renders
iTreg cells to gradually lose Foxp3, resulting in dramatically reduced Nrp1−Helios− iTreg
compartment as well as augmented intestinal inﬂammation in aged mice. Our ﬁnding
underscores a mechanistic module in which evolutionarily related transcription factors
establish a molecular program to ensure efﬁcient immune homeostasis. Furthermore, it
provides a novel target that can be potentially modulated to exclusively reinforce iTreg
stability keeping their thymic counterpart unperturbed.
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Regulatory T (Treg) cells represent a unique subtype of CD4+ T cells critical for maintaining immune homeostasis. TheX-chromosome encoded transcription factor Foxp3 is a
hallmark of Treg cells, whose continuous and stable expression is
responsible for establishing and maintaining a unique transcrip-
tional program that functionally and phenotypically distinguishes
them from other T cell lineages1–4. In the past several years,
research based on biochemical, genetic as well as cellular
immunological experiments have ﬁrmly established that, while
the major source of Treg cells within the vertebrae immune
system are thymically generated (tTreg) cells, a sizable percentage
of Foxp3+ Treg cells are generated extrathymically from naive
Foxp3− T cells as induced Treg (iTreg) cells5,6. In vivo, iTreg cells
are preferentially generated in mucosal barrier sites such as the
gut-associated lymphoid tissues (GALT), where they serve a non-
redundant role in establishing and maintenance of tolerance from
overenthusiastic immune response originating from gut-resident
microbiota and food-derived foreign antigens7–9. In iTreg cells,
Foxp3 expression initiates in response to T cell receptor stimu-
lation coupled with environmental cues involving transforming
growth factor (TGF)-β and interleukin 2 (IL-2) signaling, which
eventually converge to a set of well-deﬁned conserved non-coding
sequences (CNSs) on the Foxp3 locus through Smad2/3 and
Stat5 signaling pathways, respectively10–13.
In recent years, Foxp1, a related transcription factor of the
fork-head family, has emerged as an essential regulator of a varied
range of biological processes. In particular, within the immune
system Foxp1 has been implicated in negative regulation of
monocyte differentiation and macrophage function14. Its efﬁcient
downregulation is essential for optimal germinal center B cell
maturation by antagonizing the function of the transcription
factor Bcl615. Within the T cell compartment, Foxp1 is found to
be important for maintenance of quiescence in CD4+ and CD8+
conventional T cells by repressing IL-7Rα expression and dam-
pening Erk signaling16,17. Foxp1-deﬁcient CD4+ or CD8+ T cells
in the periphery spontaneously acquire an activated phenotype
associated with enhanced proliferation, albeit with increased
apoptosis16. By directly inhibiting IL-21 expression and limiting
inducible T-cell co-stimulator (ICOS) expression, Foxp1 also
suppresses follicular T helper cell differentiation and reduce
germinal center reaction18.
More recently, it was demonstrated that, in tumor micro-
environment, TGF-β-mediated upregulation of Foxp1 primarily
in CD8+ T cells renders them unresponsive toward immunity
against tumors. Accordingly, Foxp1-deﬁcient lymphocytes facili-
tated enhanced tumor rejection and promoted protection against
tumor re-challenge. Under these conditions, Foxp1 acts as an
integral part of the Smad signaling pathway by interacting with
Smad2 and Smad3 in a TGF-β-dependent manner19.
Owing to this recently established connection between TGF-β
signaling and regulation of Foxp1’s transcriptional activity, here
we investigate whether Foxp1 is an essential link between TGF-β
signaling and the iTreg differentiation process and ﬁnd that
Foxp1, by being readily associated with the Foxp3 locus in a TGF-
β-dependent manner, is critically required during multiple phases
of iTreg development and maturity. Using an inducible model of
temporal deletion of Foxp1 in precursor CD4+ T cells, we ﬁnd
that Foxp1 is required for optimum expression of Foxp3 during
the onset of iTreg induction. More strikingly, even a conditional
ablation of Foxp1 in iTreg cells at a later developmental time
point, when high-level transcription of Foxp3 is already estab-
lished, results in dramatic lineage instability. By contrast, the
stability of Foxp3 expression in tTreg cells remains unaffected in
the absence of Foxp1. Thus our study unravels a novel iTreg-
speciﬁc evolutionarily related transcription factor-mediated
molecular surveillance mechanism as a key determinant for the
optimal activity of the Foxp3 locus, essential for maintaining
immunological tolerance.
Results
Foxp1-deleted iTregs cannot maintain stable Foxp3 expression.
In order to determine whether Foxp1 can affect the iTreg dif-
ferentiation process, we performed a preliminary experiment to
ask whether overexpression of Foxp1 in naive T cells (Tnv) affects
the yield of iTreg cells in vivo. CD4+CD62LhiFoxp3Thy1.1− Tnv
cells sorted from Foxp3Thy1.1 mice, in which the Thy1.1 allele is
knocked into Foxp3 locus20, were transduced with control or a
retroviral vector expressing cDNA encoding the longest form of
Foxp1 (Foxp1-A)21. An in vivo iTreg conversion assay was per-
formed upon adoptive transfer of the transduced cells along with
allelically marked Treg cells from CD45.1+Foxp3GFP mice to
RAG1−/− lymphopenic hosts (Supplementary Fig. 1a, b). Indeed,
mice harboring cells overexpressing Foxp1 displayed an advan-
tage over control mice for their ability to generate iTreg cells
within the large intestine lamina propria (LI-LP), a prime site of
iTreg induction in vivo (Supplementary Fig. 1c)22.
We next wanted to determine whether the absence of Foxp1
negatively affects iTreg differentiation. CD4-Cre-driven condi-
tional deletion of Foxp1 in T cells have been previously shown to
result in an abnormally activated phenotype where essentially all
conventional CD4+ and CD8+ T cells upregulate CD44, a marker
associated with T cell activation16. Since for this study we
employed an independently generated Foxp1f/f mouse line
(Konopacki et al., manuscript in preparation), different from
that previously reported16–18, we ﬁrst generated Foxp1f/fCD4-Cre
mice to recapitulate these ﬁndings. CD4-Cre-mediated deletion of
Foxp1 in T cells resulted in speciﬁc and efﬁcient deletion of Foxp1
in all compartments of CD4+ and CD8+ T cells (Fig. 1a).
Furthermore, almost all CD4+Foxp3− and CD8+ T cells in these
mice displayed enhanced CD44 expression from a young age.
CD62L, which is downregulated in effector memory T cells, was
reduced primarily in aged mice (Fig. 1b, top and middle panels).
Interestingly, CD44 expression in Treg cells remained largely
unaffected (Fig. 1b, lower panel). While these observations were
in agreement with earlier ﬁndings16, the perpetual activated state
of the CD4+Foxp3− T cells in Foxp1f/fCD4-Cre mice, however,
precluded us from efﬁciently comparing them with wild-type Tnv
counterparts for their ability to differentiate into iTreg cells.
Hence, we reasoned that more clearly interpretable results
addressing this question is likely to be manifested in experiments
performed on Tnv cells isolated from mice harboring Treg-
speciﬁc conditional deletion of Foxp1.
To this end, we generated Foxp1f/fFoxp3IRES-YFP-Cre mice
(henceforth designated as “KO,” and control littermates
Foxp1+/+Foxp3IRES-YFP-Cre designated as “WT”; littermate
Foxp1ﬂ/+Foxp3IRES-YFP-Cre mice harboring heterozygous Foxp1
locus displayed an intermediate phenotype and were not used in
any of the experiments) by crossing mice harboring Foxp1f/f allele
with Foxp3IRES-YFP-Cre mice expressing YFP-Cre recombinase fusion
protein under the control of Foxp3 regulatory elements23. Treg-
speciﬁc deletion of Foxp1 was conﬁrmed in the peripheral lymphoid
tissues of KO mice (Fig. 1c, top panel). Within the CD4SP
thymocytes, however, ~20% Foxp3+ cells still retained Foxp1, a
population that was found to be predominantly CD24hi representing
an earlier developmental stage where presumably degradation of
residual Foxp1 protein was not yet complete24 (Fig. 1c, middle and
lower panels). Importantly, both WT and KO mice displayed
comparable percentages of CD44loCD62LhiFoxp3− Tnv populations
(shown later in supplementary Fig. 9c, where phenotypic character-
istics of WT and KO mice are discussed) permitting efﬁcient
puriﬁcation of Tnv cells for in vivo and in vitro iTreg assays.
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To directly assess a possible role of Foxp1 in iTreg
differentiation, we sorted Tnv cells from WT and KO mice and
adoptively transferred them in RAG1−/− hosts along with CD45.1
+Foxp3GFP Treg cells. Percentage of Treg conversion within the
CD45.2+ compartment was analyzed after 8 weeks. Complement-
ing our previous result, we observed striking reduction in the
yield of iTreg population arising from cells transferred from KO
donors compared to their WT counterparts (Fig. 1d).
Notably, in the Tnv compartment of KO mice at a steady state,
almost all cells are Foxp1 sufﬁcient (Fig. 1c), which is deleted only
after YFP-Cre is expressed from the Foxp3 locus. Therefore,
under this experimental setting, the transferred Tnv cells from
WT or KO mice presumably expressed comparable levels of
Foxp3 at an early stage of iTreg induction, which could not be
efﬁciently maintained upon eventual depletion of Foxp1. Indeed,
a time course analysis of in vitro iTreg assay with Tnv cells
isolated from WT or KO mice demonstrated this to be the case.
While Foxp1 expression was indistinguishable between Tnv cells
isolated from WT and KO mice at the beginning of the
experiment, 4 days after TGF-β treatment, when majority of the
seeded Tnv cells from both groups acquired robust Foxp3
expression, there was a complete shutdown of Foxp1 expression
in KO cells (Fig. 1e and Supplementary Fig. 2a). This was
accompanied by concomitant reduction in Foxp3 protein level
from day 6 after TGF-β treatment, which was more apparent on
day 8 (Fig. 1f). No difference in cell survival was observed
between the two groups within the course of the experiment
(Supplementary Fig. 2b). In-depth quantitative analyses revealed
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Fig. 1 Foxp1 is required to maintain stable expression of Foxp3 in iTreg cells. a Intracellular staining of Foxp1 to conﬁrm T-cell-speciﬁc deletion of Foxp1 in
Foxp1f/fCD4-Cre mice. b Expression of CD44 or CD62L in the indicated cell populations derived from lymph nodes of young and aged Foxp1+/−CD4-Cre
(red line) and Foxp1f/fCD4-Cre (black line) mice. c Intracellular staining to conﬁrm Treg-speciﬁc deletion of Foxp1 in the lymph nodes (top), thymus
(middle), and thymic CD24hiFoxp3+ and CD24loFoxp3+ cells (bottom) of Foxp1f/fFoxp3IRES-YFP-Cre (KO) mice compared to littermate control Foxp1
+/+Foxp3IRES-YFP-Cre mice (WT). d Representative FACS plots and quantiﬁcation of percentage of in vivo iTreg conversion within CD45.2+ compartment,
2 months after adoptive transfer of Tnv cells isolated from WT or KO mice into RAG1−/− host mice. e Foxp1 expression status within live CD4+Foxp3+ in
vitro-generated iTreg cells originating from WT- or KO-derived Tnv cells after TGF-β treatment for the indicated number of days. IgG staining is shown as
isotype control. f Status of Foxp3 expression within CD4+ live cell population in the same iTreg assay shown in e. g Mean ﬂuorescent intensity (MFI)
changes for Foxp3 and YFP-Cre in KO-derived iTreg cells relative to WT at the indicated time points. *P < 0.05, ***P < 0.0001 (Student’s t test, error bars,
s.e.m). h WT- or KO-derived iTreg cells were sorted at high purity after 3 days of TGF-β treatment and co-transferred in RAG1−/− hosts along with
allelically marked CD4+ T cells derived from CD45.1+Foxp3GFPKO mice. Representative FACS plots of Foxp3 expression within CD4+CD45.2+
compartment from lymph nodes of recipient mice at the indicated time points are shown. i Percentage of cells retaining Foxp3 (left) and its expression per
cell depicted by MFI (right) after 3 days post-transfer. j Percentage of CD45.2+ cells recovered (left) and retaining Foxp3 (right), 7 days post-transfer. Each
ﬁlled circle represents a single RAG1−/− recipient mouse analyzed. Data are representative of 2–5 independent experiments. *P < 0.05, **P < 0.01, ***P <
0.001, ****P < 0.0001 (Student’s t test, error bars, s.d.)
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that the relative abundance of Foxp3 protein and mRNA in KO-
derived iTreg cells was reduced ~50% between 3 and 7 days after
TGF-β treatment (Fig. 1g and Supplementary Fig. 2c). More
strikingly, when iTreg cells of WT and KO origin, differentiated
in vitro for 3 days, were sorted again and co-transferred in
lymphopenic RAG1−/− recipients along with CD45.1+CD4+ cells
isolated from Foxp3GFPKO mice (harboring Foxp3−null allele due
to insertion of green ﬂuorescent protein (GFP) in the Foxp3
locus25), it resulted in gradual loss of Foxp3’s expression in KO-
derived iTreg cells as early as 3 days after transfer. This was even
more exacerbated after 7 days (Fig. 1h–j). Taken together, these
results strongly suggest that a sustained high-level expression of
Foxp3 in iTreg cells is dependent on the persistent presence of
Foxp1.
In vivo-generated iTreg cells require Foxp1 to remain stable. In
light of these results, we next sought to determine whether the
ablation of Foxp1 could inﬂuence iTreg stability under in vivo
experimental conditions. For this, we generated Foxp1f/fFox-
p3eGFP-Cre-ERT2R26Y mice in which conditional loxP-ﬂanked
Foxp1 was combined with Foxp3 allele encoding inducible Cre
expressed in Treg-speciﬁc manner and a Rosa26-YFP recombi-
nation reporter allele (R26Y) enabling detection of de novo
generated iTreg cells after tamoxifen administration26. We ﬁrst
ascertained the susceptibility of the Foxp1f/f locus for Cre-
mediated recombination upon tamoxifen treatment. More than
95% of the sorted YFP+ natural Treg (nTreg) cells from these
mice were found to have lost Foxp1 expression within a week
after a single dose of tamoxifen, conﬁrming high degree of
recombination efﬁciency within the Foxp1f/f allele (Supplemen-
tary Fig. 3). CD4+Foxp3−CD25−YFP−CD62Lhi Tnv cells were
double sorted from Foxp1f/fFoxp3eGFP-Cre-ERT2R26Y or control
Foxp1+/+Foxp3eGFP-Cre-ERT2R26Y mice to nearly 100% purity
and co-transferred along with Treg cells from CD45.1+Foxp3GFP
mice into RAG1−/− hosts. Recipient mice were treated with
tamoxifen 2 weeks after cell transfer and the fate of Foxp3
expression within YFP+ cells was analyzed after 4 weeks of
treatment (Fig. 2a). The analysis involved pre-ﬁxation of the cells
with 0.5% paraformaldehyde resulting in the retention of yellow
ﬂuorescent protein (YFP) signal and ﬂow cytometric tracking of
the Foxp3+YFP+ cells generated from YFP−Foxp3− pre-
cursors27. As expected, tamoxifen treatment resulted in low level
but comparable accumulation of YFP+ cells in both experimental
groups (Fig. 2b). In order to rule out any discrepancy in the
efﬁciency of tamoxifen-mediated Foxp1 deletion in the YFP+
iTreg cells compared to nTreg cells described above, we also
conﬁrmed efﬁcient Foxp1 deletion within sorted YFP+ popula-
tion (Fig. 2c). Indeed, under these experimental conditions, the
YFP+ cells of the Foxp1-deﬁcient origin failed to optimally retain
Foxp3 expression in comparison to their Foxp1-sufﬁcient coun-
terparts (Fig. 2d). From this experiment, we concluded that under
physiologically relevant in vivo settings iTreg cells are critically
reliant on Foxp1 to preserve their acquired identity in terms of
stability of Foxp3 expression.
We also considered the possibility that the enhanced loss of
Foxp3 from iTreg cells derived from Foxp1f/fFoxp3eGFP-Cre-
ERT2R26Y mice might be associated with increased production
of pro-inﬂammatory cytokines. However, the extremely small
proportion of YFP+ cells generated precluded us from efﬁciently
addressing this question by employing the above experimental
set-up. In order to address this possibility, and increase the
yield in YFP+ cells, we therefore employed a modiﬁed version of
the experimental scheme, whereby naive T cells were brieﬂy
pulsed with TGF-β prior to transfer into RAG1−/− recipients.
Fluorescence-activated cell sorting (FACS)-puriﬁed naive
CD4+ T cells from Foxp1f/fFoxp3eGFP-Cre-ERT2R26Y or control
Foxp1+/+Foxp3eGFP-Cre-ERT2R26Y mice were ﬁrst activated and
treated with TGF-β in vitro for 24 h, following which they were
transferred to RAG1-deﬁcient hosts. After 2 days of transfer, the
hosts were treated with tamoxifen and ﬁnally sacriﬁced for
analysis after 7 days of treatment. Indeed, this modiﬁed
experimental scheme yielded more than ten-fold higher propor-
tion of YFP+ cells from both the experimental groups (compare
Fig. 2b with Fig. 2e). Furthermore, we observed signiﬁcantly
higher frequency of Foxp3−IFN-γ+ cells within the YFP+
population derived from Foxp1-deﬁcient group. Foxp3−IL17+
cells also showed an increased trend in frequency, although the
difference remained non-signiﬁcant. On the other hand, IL-4 and
IL-2 production remained largely unchanged (Fig. 2f).
Absence of Foxp1 does not affect thymic Treg stability. The
major impairment observed in iTreg cell stability in the absence
of Foxp1 raised the possibility that Foxp1 might also have similar
role in thymically generated tTreg cells. To test this, we per-
formed similar adoptive transfer and fate mapping experiments
with tTreg cells sorted directly from thymus. CD4SPFoxp3+ cells
sorted from thymus of young WT or KO mice were co-
transferred with allelically marked CD4+ T cells isolated from
Foxp3GFPKO mice to RAG1−/− hosts and analyzed for stability of
Foxp3 expression. Interestingly tTreg cells of both WT and KO
origin were exceptionally stable after 7 days of transfer (Fig. 3a).
As discussed earlier (Fig. 1c), while some of the KO tTreg cells
retained Foxp1 expression at the time of transfer, they were
conﬁrmed to have efﬁciently deleted Foxp1 during the course of
the experiment, suggesting that the unperturbed stability of
Foxp3 in tTreg cells of KO origin is not due to incomplete
deletion of Foxp1 (Fig. 3b). The observed stability of transferred
cells remained unabated even 3 weeks after transfer in all
intestinal tissues and peripheral lymph nodes analyzed (Supple-
mentary Fig. 4a). Furthermore, the phenomenon was not affected
by the developmental stage of the transferred tTreg cells, since
both CD24hi and CD24lo tTreg populations equally retained
Foxp3 (Supplementary Fig. 4b).
Finally, in order to determine whether an acute deletion of
Foxp1 in tTreg cells might differentially affect Foxp3 expression,
we performed fate mapping experiment where sorted thymically
derived tTreg cells from Foxp1f/fFoxp3eGFP-Cre-ERT2R26Y or
control mice were co-transferred with CD45.1+Foxp3−CD62Lhi
Tnv cells in RAG1−/− recipients. Tamoxifen was administered
after 2 weeks, and mice were analyzed 4 weeks later (Fig. 3c).
Similar to the previous results, tamoxifen-induced YFP+ tTreg
cells from both Foxp1-sufﬁcient or Foxp1-deﬁcient origin
displayed identical stability in Foxp3 expression (Fig. 3d). Taken
together, these results indicate that, under steady-state conditions,
thymically generated tTreg cells are not dependent on Foxp1 in
order to maintain Foxp3 expression. Therefore the dependency
on Foxp1 for sustained expression of Foxp3 is most likely an
iTreg-speciﬁc phenomenon.
Early phase of iTreg differentiation also requires Foxp1. So far
in this study, all the experiments were performed employing a
conditional deletion system where Foxp1 is deleted only after
Foxp3 is expressed, thereby conﬁrming a non-redundant role of
Foxp1 primarily in the maintenance of iTreg cells. Whether it also
contributes during the initial stage of Foxp3’s induction therefore
remained undetermined. This is because to address this question
the precursor T cells were required to be Foxp1-deﬁcient, albeit
being comparable to controls with respect to their activation state.
As discussed earlier, this could not be achieved in Foxp1f/fCD4-
Cre mice (Fig. 1b). To circumvent this issue, we generated Foxp1f/
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fFoxp3IRES-Thy1.1UbCre-ERT2 mice in which deletion of Foxp1
could be achieved ubiquitously upon tamoxifen treatment. Tnv
cells were sorted at high purity from Foxp1f/fFoxp3IRES-
Thy1.1UbCre-ERT2 mice, activated, and treated brieﬂy with
tamoxifen in vitro, after which it was washed out and cells were
rested for 48 h (Fig. 4a). Under these conditions, we could suc-
cessfully distinguish between Foxp1+ and Foxp1− precursor
T cells by intracellular staining (Fig. 4b). Furthermore, both the
populations showed similar expression of CD44 throughout,
suggesting equal activation state upon plate-bound anti-CD3/
CD28-mediated stimulation (Fig. 4c). A time course of TGF-β
treatment starting at this point demonstrated that the Foxp1-
deﬁcient compartment was signiﬁcantly compromised in indu-
cing Foxp3 compared to the Foxp1-sufﬁcient one (Fig. 4d–f).
These results along with the experiments discussed earlier
therefore established a bipartite role of Foxp1 during the iTreg
differentiation process. At the onset of TGF-β-mediated iTreg
conversion, Foxp1 is required to ensure optimum induction,
while at a later stage of development process Foxp1’s involvement
is critical to ensure sustained high-level expression of Foxp3.
Foxp1 binds Foxp3 locus to preserve its permissive state. In
addition to a promoter region, the Foxp3 locus is comprised of
well-characterized genetic elements, including three CNSs
(CNS1–3) downstream of the transcriptional start site, which have
been implicated as enhancers important for both induction and
maintenance of Foxp313,28,29. We asked whether Foxp1 associates
with Foxp3’s regulatory elements in iTreg cells. Indeed, by per-
forming chromatin immunoprecipitation (ChIP) assay we
detected robust association of Foxp1 with the promoter and the
CNS2 regions of Foxp3 (Fig. 5a). Importantly, the binding was
dependent on TGF-β and was abolished when precursor cells are
limited for Smad transcription factors (Fig. 5a, b). Furthermore,
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the binding was found to ensue in a stepwise manner whereby
Foxp1’s association with the promoter was detected ﬁrst, after 24
h, followed by CNS2 at 72 h after TGF-β treatment (Fig. 5c).
To gain insights on Foxp1-dependent molecular events
responsible for conferring stability to Foxp3 locus, we took
advantage of our earlier ﬁnding that, compared to WT, the
expression of Foxp3 in KO-derived in vitro-differentiated iTreg
cells is ~50% downregulated after 7 days of TGF-β treatment. At
this point, the effect of Foxp1 deletion appeared evident and
enabled efﬁcient harvesting of sufﬁciently expanded iTreg cells for
molecular analyses (Fig. 1e). Since Treg cell stability has been
previously correlated with cell-cycle-regulated CpG methylation
status of Foxp3 locus28,30, particularly at the promoter and CNS2
regions that speciﬁcally bind Foxp1, we ﬁrst asked whether
instability in Foxp3 expression upon loss of Foxp1 is associated
with cell division and enhanced CpG methylation. Revisiting our
previous experimental schemes, we monitored cell division of
iTreg cells by Cell Trace Violet (CTV) dilution alongside with
expression status of Foxp3. Interestingly, upon transfer to RAG1
−/− host both in vitro and in vivo, enhanced loss of Foxp3 in KO-
derived iTreg cells were found to be independent of cell division
(Supplementary Fig. 5a, b and Fig. 5d). Furthermore, bisulﬁte
sequencing of the Foxp3 locus of KO-derived in vitro-
differentiated iTreg cells did not show any correlative increase
in CpG methylation associated with reduced Foxp3, even when
status of individual CpG residues were considered (Fig. 5e).
We next asked whether the state of transcription-associated
chromatin modiﬁcations in Foxp3 locus are affected in the
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absence of Foxp1. Indeed, iTreg cells of KO origin were found
to retain dramatically lower abundance of permissive trimethy-
lation modiﬁcations of histone H3 at lysine 4 (H3-K4me3) after
7 days in culture compared to WT (Fig. 5f, top panel). Notably,
the modiﬁcation was undetectable in Tnv cells and was equally
abundant in both WT- and KO-derived iTreg cells in an earlier
3-day culture, at which point Foxp1 was not efﬁciently deleted
(Supplementary Fig. 6 and Fig. 1e). Acetylated H3-K9/14 (H3-
K9/K14Ac), another representative mark for permissive
chromatin modiﬁcation, was also found to be dramatically
affected in KO-derived iTreg cells after 7 days in culture. In
contrast, the inhibitory H3-K9me3 modiﬁcation remained
unchanged (Fig. 5f, middle and lower panels). Taken together,
these results implicated an active role of Foxp1 in preserving
favorable state of chromatin modiﬁcations of the Foxp3 locus
by being physically associated with its regulatory elements. On
the other hand, its potential involvement in directly restoring
cell-cycle-dependent CpG hypo-methylation status appears less
likely.
Compromised iTreg homeostasis in Foxp1f/fFoxp3YFP-Cre mice.
In order to determine the functional signiﬁcance of the observed
roles of Foxp1 in the iTreg differentiation process, we next per-
formed in-depth analyses of WT and KO mice and asked whether
Treg-speciﬁc deletion of Foxp1 resulted in altered iTreg home-
ostasis in vivo. First, upon overall characterization of the Treg cell
population we observed a modest but signiﬁcant reduction in the
percentage of CD4+Foxp3+ Treg cells, although not in absolute
numbers, particularly in peripheral lymph nodes and mesenteric
lymph nodes of the KO mice compared to WT (Fig. 6a). Fur-
thermore, the KO mice displayed enhanced Treg activation,
characterized by increased percentage of CD62LloCD44hi and
CD103+ Treg populations, as well as proliferation, determined by
increased expression of the proliferation marker Ki67 (Fig. 6b, left
panel). However, the difference in frequency of Treg cells
expressing these markers do not always consistently reﬂect
changes in the absolute number of cells (Fig. 6b, right panel).
Importantly, consistent with the results so far, we observed
dramatically reduced Treg-speciﬁc expression of Dapl1 and
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decreased frequencies of Foxp3+Nrp1− or Foxp3+Helios− Treg
cells, all of which are associated markers of the iTreg population
(Supplementary Fig. 7a–c)22,31,32. In particular, the Foxp3+Nrp1
−Helios− population, which we anticipated to be most stringent
representative of iTreg cells, was decreased speciﬁcally, both in
frequency and numbers, within peripheral lymphoid organs and
was most prominent in aged mice (Fig. 6c and supplementary
Fig. 7d, e). These observations, along with the results so far,
implicated that Treg-speciﬁc deletion of Foxp1 indeed results in
reduced iTreg frequency in KO mice.
In spite of being signiﬁcantly reduced, the KO mice still did
harbor a small but sizable population of iTreg cells
(Supplementary Fig. 7b, c and Fig. 6c). In order to characterize
this population, we sorted Foxp3+Nrp1lo and Foxp3+Nrp1hi cells
from KO mice and their littermate controls (Supplementary
Fig. 8a) and performed real-time PCR as well as in vitro
suppression assay to determine the expression status of Foxp1 and
Foxp3 and their suppressive capacity, respectively. Interestingly,
by real-time PCR analysis we observed a signiﬁcant level of
residual Foxp1 mRNA still remaining in the Foxp3+Nrp1lo
population derived from KO mice (Supplementary Fig. 8b).
Although this level of Foxp1 mRNA is 10-fold lower than that
observed in WT Foxp3+Nrp1lo population, it is signiﬁcantly
higher than that observed in Nrp1hi, for which the level of Foxp1
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mRNA was found to be 40-fold reduced in the KO cells compared
to WT (Supplementary Fig. 8b). As expected, by intracellular
FACS staining, a small fraction of these KO Foxp3+Nrp1lo cells
were found to still retain Foxp1 protein (Supplementary Fig. 8c).
Furthermore, the expression of Foxp3 in Nrp1lo KO Treg cells
was found to be unaltered, both at the mRNA and protein level
(Supplementary Fig. 8d, e). These observations suggested that the
Nrp1lo Treg population in the KO mice most likely represents a
small proportion of “recently generated” iTreg cells in which the
process of Foxp1deletion is still ongoing, and its effect on Foxp3
expression would presumably be more apparent with time.
Indeed, rendering enough time to the KO Nrp1lo Treg cells, upon
culturing them in vitro for 3 days, resulted in complete deletion of
Foxp1, eventually leading to instability in Foxp3’s expression
(Supplementary Fig. 8f, g). Finally, in an in vitro suppression
assay, while the Nrp1hi populations were comparable, the Nrp1lo
population derived from KO cells displayed a modest reduction
in suppressive capacity compared to their WT counterparts
(Supplementary Fig. 8h).
Foxp1 deletion is frequently associated with enhanced
apoptosis in several cell types16,33,34. Therefore, although
enhanced cell death was not detected in vitro (Supplementary
Fig. 2b), the reduced size of Treg compartment and heightened
Treg cell activation and proliferation in KO mice raised the
possibility that increased susceptibility to cellular turnover
resulting from Foxp1 depletion may contribute to the observed
scarcity in iTreg population in these mice. In order to address
this, we crossed the Foxp1f/fFoxp3IRES-YFP-Cre mice with mice
expressing hematopoietic cell-speciﬁc transgene encoding the
antiapoptotic protein Bcl2 (called Vav-Bcl2tg and resultant mice
referred to as WT-Tg and KO-Tg). Transgenic expression of Bcl2
almost completely rectiﬁed the heightened activation and
proliferation as well as restored the diminished total Treg
frequency in KO-Tg mice. However, these mice still remained
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signiﬁcantly compromised for the Foxp3+Nrp1−Helios− iTreg
compartment, suggesting that the reduction of iTreg cells in KO
mice is not due to speciﬁc increase in cell death within this
population (Fig. 6d).
Subsequent analyses of the KO mice displayed moderate increase
in cellularity speciﬁcally within lymph nodes compared to WT
counterparts (Supplementary Fig. 9a), and while the CD4+ and
CD8+ T cell compartments were largely unaltered (Supplementary
Fig. 9b), this was associated with marginally increased frequencies
of CD62LloCD44hiFoxp3− effector memory population, as well as
increased proportion of IFN-γ-producing effector and cytotoxic
T cells within lymph nodes (Supplementary Fig. 9c, d).
Intestinal inﬂammation in Foxp1f/fFoxp3IRES-YFP-Cre mice.
Since in this study we sought to focus on the phenotypes asso-
ciated with impaired iTreg homeostasis, we speciﬁcally investi-
gated the intestinal immune system associated with GALT, where
we reasoned the iTreg-related phenotypes are likely to be mani-
fested most. As in secondary lymphoid tissues, Foxp3+Nrp1
−Helios− iTreg population was signiﬁcantly reduced in Peyer’s
patches, small intestine, and LI-LP, the difference being of max-
imum magnitude in the LI-LP (Fig. 7a). The GALT-tissue-derived
T cells displayed no detectable differences in terms of pro-
inﬂammatory cytokine expression at young age (Fig. 7b, top left
and middle panel, Supplementary Fig. 10 left panel). However,
there were signiﬁcantly increased frequencies of IL-17-producing
T cells speciﬁcally within the LI-LP of aged mice (Fig. 7b, top
right and lower panel, Supplementary Fig. 10 right panel). Fur-
thermore, histopathological examination of colonic tissues
derived from aged KO mice revealed submucosal thickening and
crypt architectural distortion along with lymphocytic inﬁltration
resulting in high histological score, pointing toward disruption of
immune homeostasis at the mucosal surface (Fig. 7c).
In order to determine the relative contributions of impaired
iTreg homeostasis versus functional incompetence of tTreg cells
in gut-associated inﬂammation upon Foxp1 deletion, we next
employed a cell transfer model of colitis. Colitogenic CD4+Foxp3
−CD45RBhi T cells were transferred to RAG1−/− recipients either
alone, along with total WT nTreg cells, with sorted tTreg cells
from the thymus of young WT or KO mice, or with 3 days in
vitro-differentiated iTreg cells derived from WT or KO mice. Of
note, as shown earlier (Fig. 1h left panel) at this time point, both
WT- and KO-derived iTreg cells retain comparable levels of
Foxp3. As expected, severe body weight loss that developed upon
CD45RBhi cell transfer alone could be completely prevented by
total WT nTreg cells and partially by WT iTreg cells, given the
non-redundant roles of thymic and induced Treg cells in
preserving mucosal tolerance35,36. However, co-transfer of in
vitro-induced KO iTreg cells failed to provide any protection as
indicated by their increased body weight loss and inﬂamed colon
(Supplementary Fig. 11a). Notably, similar result was obtained
when, as an alternative approach, Tnv cells from Foxp1f/
fFoxp3eGFP-Cre-ERT2R26Y or littermate Foxp1+/+Foxp3eGFP-Cre-
ERT2R26Y mice were used in the presence of 4-OH tamoxifen as
sources of YFP+ iTreg cells (Supplementary Fig. 11b, c).
Interestingly, the tTreg cells derived from KO mice remained
largely protective, and while mice co-transferred with KO derived
tTreg cells displayed a tendency of increased weight loss
compared to the WT tTreg counterparts toward later time
points, the difference remained non-signiﬁcant throughout the
course of the experiment (Supplementary Fig. 11a). Taken
together, these results revealed that Treg-speciﬁc deletion of
Foxp1 is moderately associated with lymphoproliferative disorder
and age-associated inﬂammation at mucosal sites, a major cause
of which can be attributed to impaired iTreg homeostasis.
Finally, the above results prompted us to investigate whether
Treg-speciﬁc ablation of Foxp1 might trigger these mice to
respond to dextran sodium sulfate (DSS)-induced colitis with
exacerbated disease severity. Indeed, even at a young age of
6–8 weeks, chronic colitis induction with 2% DSS in KO mice
resulted in increased body weight loss accompanied with
epithelial degeneration, crypt destruction, immune cell inﬁltra-
tion as well as characteristic focal areas of squamous metaplasia,
and overall heightened histological scores (Fig. 7d, e). The
phenotype was accompanied with signiﬁcant increase in IL-17+
and IFN-γ+IL-17+ effector T cell populations in the large
intestine (Fig. 7f). Thus Treg-speciﬁc deletion of Foxp1 rendered
mice with enhanced susceptibility to a physiologically relevant
experimental model of colitis.
Discussion
Stable commitment to speciﬁc types of T cell subsets is broadly
dependent on the expression of lineage-specifying transcription
factors. However, potential involvement of additional regulators
in establishing cell-type-speciﬁc genetic landscape for sustained
maintenance of the lineage-specifying factor appears evident.
Substantial effort is now being devoted to identify such crucial
molecular elements amenable to be ﬁne-tuned in order to bolster
or undermine the unilateral propagation of a speciﬁc lineage in
the context of health and disease. In this study, by identifying
Foxp1 as a key determinant for prolonged stability of the Foxp3
locus, we signiﬁcantly advance our basic understanding of the
molecular events contributing to immune cell homeostasis. Fur-
thermore, the unique dependence of iTreg cells on the presence of
Foxp1 makes these ﬁndings particularly interesting since a major
bottleneck in utilizing in vitro-generated iTreg cells for greater
therapeutic purpose is their intrinsic unstable nature37–40.
We found that Foxp1 can associate with the Foxp3 locus upon
TGF-β treatment, ﬁrst with its promoter, followed by the
enhancer region CNS2. The stepwise pattern of binding, along
with previous ﬁndings where Foxp1 was reported as an integral
part of Smad signaling pathway in tumor-inﬁltrated CD8+
T cells, strongly indicated that its initial recruitment to Foxp3
promoter is likely a Smad-dependent event. Indeed, in in vitro-
generated iTreg cells where precursor T cells were derived from
Smad2f/fSmad3+/−CD4-Cre mice, the binding was completely
abolished. Of note, both Smad2 and Smad3 alleles were targeted
for these experiments in order to minimize redundancy observed
previously in Smad signaling. Furthermore, a heterozygous
Smad3+/− allele was employed instead of Smad3−/−, since
complete deletion of both Smad alleles results in overt auto-
immunity12. The CNS2 region is a well-established genetic ele-
ment shown to be critical for maintaining Foxp3 stability in pan
nTreg population13,28,29. The CNS2 locus is enriched for CpG
sites whose methylation status largely correlates with enhanced
stability of the Foxp3 locus in a cell-cycle-dependent manner28.
Interestingly, we found that the stability-exerting function of
Foxp1 on the Foxp3 locus, within the experimental conditions
utilized in our study, is independent of cell division and its
associated CpG methylation status. One caveat of these experi-
ments is that under in vitro differentiation conditions the overall
CpG methylation of the CNS2 region is minimally reduced even
in WT iTreg cells. However, when individual CpG residues within
the CNS2 region are analyzed, consistent with a previous report41,
we found that unlike other sites, few speciﬁc CpG residues, for
example, residues 2, 10, 11, and 12, displayed enhanced deme-
thylation. These observations suggest a potentially sequential
nature of events in which certain key CpG residues within CNS2
are demethylated ﬁrst. However, the extent of demethylation even
within these speciﬁc residues remained comparable between WT-
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and KO-derived iTreg cells. Contrary to these results, deletion of
Foxp1 dramatically affected permissive chromatin modiﬁcations
within the Foxp3 gene locus that correlated well with its dimin-
ished transcription. Although these results point toward an
apparent disconnect between DNA hypomethylation and per-
missive chromatin modiﬁcation, nonetheless they are in agree-
ment with previous ﬁndings that, in TGF-β-mediated ex vivo-
differentiated iTreg cells, enhanced H3K4 trimethylation appears
even in the absence of DNA hypomethylation30,42. This is not
unusual given that our understanding of precise mechanistic
events contributing toward the molecular complexity of histone
remodeling and DNA demethylation, and its link with tran-
scriptional state of gene expression is still evolving43. These
results therefore are suggestive of multiple layers of molecular
events associated with a favorable transcriptional state of Foxp3 in
iTreg cells.
Whether identical mechanisms exist during de novo differ-
entiation of iTreg cells under physiological conditions, however,
is not entirely clear due to technical constraints. Nevertheless,
genetic fate mapping experiments unequivocally demonstrated
that persistent expression of Foxp3 within in vivo-differentiated
iTreg cells indeed is greatly dependent on Foxp1. Furthermore,
**
***
***
Helios
N
rp
1
WT KO
43.6
22.6 20.5
13.4 18.7
25.1
LI-LP
45.0
11.2
WT KOWT KOWT KO
PP SI LI
1.03
11.5
2.63
2.12
IL17
6-week-
old mice
36-week-
old mice
WT
KO
mLN PP SI LI
W
T
KO W
T
KO W
T
KO W
T
KO
6–9-week-
old mice
36–40-week-
old mice *
WT KO
H
is
to
lo
gy
 s
co
re
**
WT
KO
H
is
to
lo
gy
 s
co
re
****
WT KO
IF
N
γ
IL17
14.6 0.2
3.7
7.9 2.3
10.0
**
*
WT KO
WT KO
WT KO
0
5
10
15
20
25
0
2
4
6
80
90
100
110
KO
WT
0 5 10 20 2515
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
%
 b
od
y 
we
ig
ht
 c
ha
ng
e
Days
*
*
*
*
*
*
* *
* *
*
*
*
*
*
*
WT
KO
105
105
104
104
103
103
102
102
0
1051041031020
0
20
15
10
5
60
40
20
0
0
20
15
10
5
0
4
3
2
1
0
4
3
2
1
0
%
 H
el
io
s–
N
rp
1–
 
Tr
eg
s
%
CD
4+
IL
17
+
105
105
104
104
103
103
102
102
0
Q4
81.5%
Q4
79.7%
0
%
IL
17
+
%
IF
Nγ
+
IL
17
+
a b c
d
e f
Fig. 7 Inﬂammation in the intestinal mucosa of Foxp1f/fFoxp3IRES-YFP-Cre mice. a Representative ﬂow cytometric analysis from LI-LP (top) and quantiﬁcation
(bottom) of Foxp3+Nrp1−Helios− iTreg population within GALT tissues from WT and KO mice. b Representative ﬂow cytometric analysis from LI-LP (top)
and quantiﬁcation of percentage of IL17-producing CD4+Foxp3− cells in 6–9-week- (middle panel) and 36–40-week-old (lower panel) WT and KO mice.
c Representative histological sections (left) and histological scoring (right) of colon from aged WT and KO mice. Sections were stained with hematoxylin
and eosin. Original magniﬁcation ×100, scale bar equals 100 µm. d Susceptibility of WT and KO mice to 2% DSS-induced chronic model of colitis. Body
weight loss over time is presented as a read out of disease severity. Two-way ANOVA with Bonferroni post-test was applied and statistically signiﬁcant
differences in mean values is considered at P < 0.05. Data are representative of two experiments (n= 10 for each group). e Histological sections (left) and
scoring (right) of colon from representative DSS-treated WT and KO mice. Sections were stained with hematoxylin and eosin. Original magniﬁcation ×100,
scale bar equals 100 µm. f Intracellular staining and quantiﬁcation of colonic IFN-γ- and IL17-producing CD4+Foxp3− cells from representative DSS-treated
mice. PP Peyer’s patches, SI small intestine, LI large intestine, mLN mesenteric lymph nodes. Data are representative of 2–4 independent experiments. *P <
0.05, **P < 0.01, ***P < 0.001, ****P<0.0001 (Student’s t test, error bars, s.d.)
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Treg-speciﬁc deletion of Foxp1 resulted in signiﬁcantly reduced
Nrp1−Helios− iTreg population, which was phenotypically
reﬂected in enhanced age-related and DSS-induced intestinal
inﬂammation in these mice. Of note, another potential Treg-
speciﬁc function of Foxp1 that was not the primary focus of this
study is that it is likely to be directly contributing to Treg gene
expression program by being physically associated with
Foxp344,45. By employing a co-transfer model of colitis induction,
however, we observed that unlike Foxp1-deﬁcient in vitro-
differentiated iTreg cells, the Foxp1-deﬁcient tTreg cells remained
largely protective compared to their wild-type counterparts. This
observation suggests that at least a major contributing factor for
intestinal inﬂammation in mice bearing Treg-speciﬁc deletion of
Foxp1 is impaired iTreg homeostasis.
One outstanding question is why are iTreg cells speciﬁcally
affected in the absence of Foxp1? It seems reasonable to hypo-
thesize that the differential requirement of Foxp1 to confer sta-
bility to Foxp3 locus in tTreg and iTreg cells is a direct
consequence of distinct molecular features governing Foxp3’s
transcriptional state in these cells. Indeed, there is accumulating
evidence suggesting differential roles of various transcription
factors on tTreg and iTreg differentiation and functions. For
example, Satb1, a global genome organizer and a regulator of
transcription has been proposed to act as a pioneering factor
critical for initiating Foxp3’s expression in thymic Treg precursor
cells. On the other hand, deletion of Satb1 in the periphery results
in enhanced iTreg homeostasis46. The transcription factor KLF2
was reported to be crucial exclusively for iTreg induction47, while
another transcription factor musculin was recently reported to
promote unidirectional stability in iTreg cells by inhibiting Th2-
speciﬁc gene expression48.
A second possibility contributing to Foxp1 dependence in
iTreg cells was that, compared to tTreg cells, Foxp1 plays a more
prominent antiapoptotic role in iTreg cells. As a result in Foxp1f/
fFoxp3IRES-YFP-Cre mice, Foxp1’s ablation in iTreg cells might
have resulted in preferential cell death in this compartment even
before Foxp3’s expression is altered. However, two independent
observations suggest that this is unlikely. First, in fate mapping
experiments employing Foxp3eGFP-Cre-ERT2R26Y mice, the fre-
quency of tamoxifen-induced YFP+ cells arising from Foxp1-
sufﬁcient and Foxp1-deﬁcient background were nearly identical
even after 4 weeks post tamoxifen treatment. Second, the
diminished Foxp3+Nrp1−Helios− iTreg compartment in Foxp1f/
fFoxp3IRES-YFP−Cre mice remained unaltered after overexpression
of the antiapoptotic factor Bcl2.
In summary, our results demonstrate Foxp1 as a cardinal
mediator of the iTreg differentiation process. We propose that
such non-redundant requirement of an evolutionarily related
sibling of a key lineage-determining factor may represent a gen-
eral principle to ensure stability in cellular differentiation. Finally,
since Treg cells are widely pursued as an option for adoptive
transfer-mediated cellular therapy, our ﬁnding offers a potentially
novel therapeutic target to ensure long-term stability of in vitro-
expanded patient-derived iTreg cells for clinical applications.
Methods
Mice. Foxp1f/f mice were generated in the Rudensky laboratory in University of
Washington, Seattle. Foxp3IRES-YFP-Cre mice23, Foxp3eGFP-Cre-ERT2R26Y mice26,
Foxp3GFPKO mice25, Foxp3GFP mice49, and Foxp3Thy1.1 mice20 are described
elsewhere. Vav-Bcl2tg mice50 was a gift from Dr. Jerry M. Adams at the Walter and
Eliza Hall Institute of Medical Research, Australia. Smad2f/fSmad3+/−CD4-Cre
mice12 was a gift from Dr. Akihiko Yoshimura, Keio University School of Medi-
cine, Japan. All mice except Smad2f/fSmad3+/−CD4-Cre mice were generated on or
backcrossed to C57BL/6 background or C57BL/6 with CD45.1 allele wherever
applicable. Smad2f/fSmad3+/−CD4-Cre mice are in C57BL/6 and 129β mixed
background. All animals were maintained in speciﬁc pathogen-free barrier facilities
and were used in accordance with protocols approved by the POSTECH Institu-
tional Animal Care and Use Committee.
FACS staining and antibodies. For surface staining, ﬂuorochrome-conjugated
antibodies were purchased from eBioscience, Biolegend, Tonbo, and R&D Bios-
ciences. Anti-CD4 (GK1.5), anti-CD8 (53−6.7), anti-CD25 (PC61.5), anti-CD24
(M1/69), anti-CD103 (2E7), anti-GITR (DTA-1), anti-ICOS (C398.4A), anti-
CTLA4 (UC10-4B9), anti-Ki67 (16A8), anti-CD62L (MEL-14), anti-CD44 (IM7),
anti-CD45.2 (104), anti-CD45.1 (A20), anti-Nrp1 (3DS304M), anti-TCRβ (H57-
597), and anti-Thy1.1 (OX-7) were used at 1:400 dilution. Anti-Nrp1 (3DS304M)
was used at 1:25 dilution.. For intracellular staining, surface-stained cells were ﬁxed
and permeabilized with a Foxp3 Staining Kit (eBioscience) according to the
manufacturer’s instruction and were stained with the following antibodies at 1:200
dilution: anti-Foxp3 (FJK-16s), anti-Helios (22F6), anti-IFN-γ (XMG1.2), anti-IL-
17A (eBio17B7), anti-IL-4 (11B11), and anti-IL-13 (eBio13A) wherever applicable.
For intracellular staining of Foxp1, cells were washed, ﬁxed, and permeabilized as
described and then incubated with anti-Foxp1 (Cell Signaling Technologies (CST)
#2000S) antibody at 1:250 dilution. Subsequently, they were washed and further
stained with anti-Rabbit IgG (CST-Poly4064) at 1:500 dilution followed by intra-
cellular staining of Foxp3 and other surface markers. To reduce background, Fc
Blocker was used before each staining step. For in vitro cultures, cells were stained
ﬁrst with Ghost Violet 510 Viability Dye prior to surface or intracellular staining at
1:1000 dilutions. PE Annexin V Apoptosis Detection Kit (BD PharmingenTM) was
used for viability assay of cells cultured for in vitro iTreg induction. Stained cells
were analyzed in LSR Fortessa SORP ﬂow cytometer with the DIVA software (BD
Biosciences) and were analyzed by FlowJo (Treestar). Gating strategies for FACS
sorting and analyses are described in Supplementary Fig. 12 and 13, respectively.
Histology. Mouse tissues were ﬁxed in 10% neutral-buffered formalin and were
further processed by routine staining with hematoxylin and eosin. Blinded
assessment of at least three sections of each tissue per mouse was performed by
expert pathologist. Histological assessment of colon injury was performed at ×100
as previously described51. Histology score was generated on a scale from 0 to 4 as
follows: 0, normal tissue; 1, inﬂammation with scattered cellular inﬁltration and no
signs of epithelial degeneration; 2, moderate inﬂammation with multiple foci and/
or mild epithelial ulcerations; 3, severe inﬂammation with marked wall thickening
and/or ulcerations in >25% of the tissue; and 4, inﬂammation with inﬂammatory
cell inﬁltration and/or >75% of the tissue section affected. An average of at least
three ﬁelds of view per colon was evaluated blindly for each mouse.
In vitro iTreg differentiation. CD4+ cells were prepared from Foxp1+/+Fox-
p3IRES-YFP-Cre or Foxp1f/fFoxp3IRES-YFP-Cre by negative selection of total lympho-
cytes from spleen and peripheral lymph nodes using MACS LD columns (Miltenyi
Biotec). The enriched cells were sorted using MOFLO ASTRIOS Flow Cytometer
System (Beckman Coulter) to isolate naive CD4+CD62Lhi (YFP− for Foxp3IRES-
YFP-Cre reporter mice) T cells from the total CD4+ cells. The purity of sorted T cell
populations routinely exceeded 99%. These cells were activated with plate-bound
anti-CD3(1 μg/ml) and anti-CD28 (1 μg/ml) in the presence of 2 ng/ml premium
grade human TGF-β (Miltenyi Biotec) and 50 IU/ml of recombinant human IL-2
(Miltenyi Biotec) and cultured in complete RPMI1640. For prolonged cultures till
6–8 days, cells were split daily, starting from 2 days after TGF-β treatment in
complete RPMI1640 supplemented with 50 IU/ml IL-2.
Adoptive transfer and in vivo Treg cell maintenance assay. Sorted CD45.2
+CD4+Foxp3-CD62Lhi Tnv cells from WT and KO mice were mixed with sorted
CD45.1+ Treg cells (1:3) and adoptively transferred intravenously (i.v.) to RAG1
−/− host mice. After 2 months of transfer, mice were analyzed to determine Foxp3
+ cells within CD45.2+ population. For in vivo iTreg maintenance assay, 2 × 105
FACS-sorted in vitro-generated iTreg cells from day 3 culture were co-injected with
6 × 105 CD4+ T cells enriched from CD45.1+Foxp3GFPKO mice into
RAG1−/− recipient mice. For an analogous experiment with thymic Treg cells,
CD4SPFoxp3+ or CD4+Foxp3+CD24hi or CD24lo Treg cells were sorted from
thymus of WT or KO mice wherever applicable. Thymic Treg cells were mixed
with CD4+ T cells enriched from CD45.1+Foxp3GFPKO cells at 1:3 ratio and i.v.
injected to RAG1−/− host mice.
In vivo Treg fate mapping experiments. CD45.2+CD4+CD25−GFP−CD62Lhi
Tnv cells (with >99.7% purity) from Foxp1f/fFoxp3GFP-Cre-ERT2R26Y or Foxp1
+/+Foxp3GFP-Cre-ERT2R26Y mice were transferred together with sorted CD45.1
+Foxp3+ Treg cells in RAG1−/− hosts who received a single oral gavage of
tamoxifen (Sigma) in soybean oil (8 mg/20 g of body weight) 1, 2, or 5 weeks after
cell transfer. Four weeks after treatment, recipient mice were sacriﬁced and YFP+
cells were analyzed. For ﬂow cytometric analysis, CD4+ cells were enriched from
spleen and peripheral lymph nodes and subjected to a staining protocol adapted
from ref. 27. Brieﬂy, cells were pre-ﬁxed with 0.5% paraformaldehyde for 10 min in
order to retain the tamoxifen-induced YFP signal, before they were subjected to
intracellular staining for Foxp3.
Retroviral transduction. Foxp1A cDNA was subcloned in MSCV-IRES-EGFP
(MigR1-GFP) vector and transiently transfected into retroviral packaging cell line
Platinum-E, using Fugene HD Transfection Reagent (Promega). For transduction,
CD4+CD62LhiThy1.1− Tnv cells from Foxp3Thy1.1 mice were sorted and activated
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with plate-bound anti-CD3 and anti-CD28 overnight, followed by spin-infection
with viral supernatant that was supplemented with HEPES and polybrene.
Chromatin immunoprecipitation. ChIP for Foxp1 was performed using a protocol
developed by Upstate Biotechnology (17-295). Brieﬂy, chromatin was prepared
from 5 × 106 cells either sorted from mice or in vitro differentiated at the indicated
time points and subjected to immunoprecipitation overnight at 4 °C with rabbit
anti-Foxp1 (CST, D35D10 XP, #4402) or normal rabbit IgG (CST, #2729 S) from
Cell Signaling Technology. Crosslinks were reversed and enrichment of the indi-
cated DNA sequences were determined by quantitative real-time PCR with a SYBR
Green (USB VeriquestTM Fast SYBR qPCR master mix with ROX) followed by
quantiﬁcation with the ViiA™7 Software v1.2.2. Within the regions of interest,
Foxp1 binding is represented as the percentage of enrichment over input, and
calculation was conducted using the change-in-threshold (2–ΔΔCT) method52. To
determine the status of histone modiﬁcations, ChIP analysis was performed as
described elsewhere13. Antibodies speciﬁc for different histone modiﬁcations were
from Abcam ((anti-H3K9me3(ab8898), anti-H3K4me3(ab8580), and Thermo
Fisher Scientiﬁc (anti-H3K9/14/Ac (49-1010)). The sequences for primer pairs
used for ChIP–quantitative PCR analyses are mentioned in supplementary table 1.
Gene expression analysis. Total RNA was isolated from sorted in vitro-induced
iTreg cells populations using TRIZOL reagent (Ambion) and quantiﬁed in
Nanodrop2000c (Thermo Fischer), and cDNA was reverse transcribed using
Quantitect reverse transcription kit (QIAGEN) following the manufacturer’s
instruction. Quantitative real-time PCR was done with Fast SYBR Green (USB
VeriquestTM Fast SYBR qPCR master mix with ROX) with the set of primers
mentioned in supplementary table 1. A ViiA7 Real-Time PCR system (Life
Technologies) was used for all reactions and detection. Quantiﬁcation of relative
mRNA expression was normalized to the expression of the control gene encoding
Hprt and relative expression was calculated by change-in-threshold method.
Adoptive-transfer-induced colitis. Splenic CD4+Foxp3−CD45RBhi cells were
sorted from Foxp3GFPCD45.1+ mice and mixed with total wild-type nTreg cells or
Treg cells sorted directly from the thymus of Foxp1+/+Foxp3IRES-YFP-Cre or Foxp1f/
fFoxp3IRES-YFP-Cre mice. For iTreg co-transferred groups, Treg cells were ﬁrst
induced in vitro from Foxp1+/+Foxp3IRES-YFP-Cre- or Foxp1f/fFoxp3IRES-YFP-Cre-
derived naive T cells, and YFP+ iTreg cells were sorted after 3 days of induction.
Colitis was induced in RAG1-deﬁcient hosts by i.v. injection of 7.5 × 10 5
CD45RBhi splenocytes along with 2.5 × 105 indicated Treg cells. Mice weight was
recorded blindly once weekly for 8 weeks. Colon were isolated from hosts and
weighed at the end of the experiment.
DSS-induced colitis. Chronic colitis was induced by the provision of 2% (wt/vol)
DSS (molecular mass, 36–50 kilodaltons; MP Biomedicals) in drinking water ad
libitum. Two cycles of DSS and 2 cycles of normal drinking water (7 days/cycle)
was provided alternatively. Mice weight was recorded blindly from day 1 of DSS
through day 25 of treatment. At the end of the experiment, mice were sacriﬁced by
CO2 asphyxiation and colon were removed and lymphocytes were isolated for
FACS analyses. Horizontal tissue sections from colon were also ﬁxed for further
histopathological analyses.
Bisulﬁte sequencing. Total genomic DNA from in vitro-induced Treg cells at day
7 in culture was isolated using the Accuprep Genomic DNA Extraction Kit (Bio-
neer). Bisulﬁte conversion of DNA was performed with the MethylEasy Xceed Kit
(Human Genetic Signature). PCR amplicon from loci of interest was generated
from this treated DNA using primers mentioned in supplementary table 1. After
electrophoresis to conﬁrm the size, these PCR products were then puriﬁed from
agarose gel using HiGene Gel and PCR puriﬁcation system (Biofact). Library
preparation followed by high-throughput sequencing (150 bp, paired-end) of the
DNA was performed by Theragen Etex (Republic of Korea). High-throughput
sequencing (150 bp, paired-end) of the prepared DNA libraries was performed
using Illumina HiSeq4000. The sequenced reads were trimmed by quality (Phred
quality score cutoff 20) using Trim Galore (version 0.4.2, https://www.
bioinformatics.babraham.ac.uk/projects/trim_galore/) with Cutadapt (version1.12)
(ref. http://journal.embnet.org/index.php/embnetjournal/article/view/200/479).
The trimmed reads were mapped to amplicon sequences using Bismark (version
0.17.0)53. The ratio of methylated and unmethylated CpG at each CpG site was
calculated from the Bismark analysis.
In vitro suppression assay. Sorted Nrp1+YFP+ and Nrp1−YFP+ cells from
Foxp1+/+Foxp3IRES-YFP-Cre or Foxp1f/fFoxp3IRES-YFP-Cre mice were incubated with
responder cells (CD4+Foxp3− CD62Lhi) that were pre-pulsed with CTV for 10
min at 37 °C. Cells were washed in phosphate-buffered saline twice and immedi-
ately used. T-cell-depleted splenocytes (1 × 105 cells) were mixed with CTV-pulsed
responder cells (5 × 104) and the indicated amounts of Treg cells of each group
along with 0.3 μg/ml of anti-CD3 and plated in round-bottom 96-well plate. Cells
were cultured for 4 days and their proliferation was analyzed by ﬂow cytometry for
determining the dilution and mean ﬂuorescent intensity of CTV intensity.
Statistics. Statistical analysis was performed using Graphpad Prism 6.0 (Graph
Pad software, La Jolla, CA, USA) operating unpaired two-tailed Student’s t test or
two-way analysis of variance with Bonferroni post-test where applicable. Statisti-
cally signiﬁcant differences in mean values were considered at P < 0.05.
Data availability
All data that support the ﬁndings of this study are available from the corresponding
author upon request. The bisulﬁte sequencing data were deposited in the Gene
Expression Omnibus (NCBI) data repository under accession number GEO:
GSE118595.
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